Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Octreotide (GH) 50 microgram/mL injection, ampoule |
has intended active ingredient |
True |
octreotide |
Inferred relationship |
Some |
1372419828 |
Octreotide (GH) 50 microgram/mL injection, ampoule |
has Australian BoSS |
True |
octreotide |
Inferred relationship |
Some |
1372419828 |
Octreotide (GH) 500 microgram/mL injection, ampoule |
has Australian BoSS |
True |
octreotide |
Inferred relationship |
Some |
922253708 |
Octreotide (GH) 500 microgram/mL injection, ampoule |
has intended active ingredient |
True |
octreotide |
Inferred relationship |
Some |
922253708 |
Octreotide (GH) 100 microgram/mL injection, ampoule |
has Australian BoSS |
True |
octreotide |
Inferred relationship |
Some |
993190100 |
Octreotide (GH) 100 microgram/mL injection, ampoule |
has intended active ingredient |
True |
octreotide |
Inferred relationship |
Some |
993190100 |
Octreotide Depot (Teva) (octreotide 10 mg) modified release injection, 10 mg vial |
has intended active ingredient |
True |
octreotide |
Inferred relationship |
Some |
1994492167 |
Octreotide Depot (Teva) (octreotide 10 mg) modified release injection, 10 mg vial |
has Australian BoSS |
True |
octreotide |
Inferred relationship |
Some |
1994492167 |
Octreotide Depot (Teva) (octreotide 20 mg) modified release injection, 20 mg vial |
has Australian BoSS |
True |
octreotide |
Inferred relationship |
Some |
389715184 |
Octreotide Depot (Teva) (octreotide 20 mg) modified release injection, 20 mg vial |
has intended active ingredient |
True |
octreotide |
Inferred relationship |
Some |
389715184 |
Octreotide Depot (Teva) (octreotide 30 mg) modified release injection, 30 mg vial |
has intended active ingredient |
True |
octreotide |
Inferred relationship |
Some |
344775437 |
Octreotide Depot (Teva) (octreotide 30 mg) modified release injection, 30 mg vial |
has Australian BoSS |
True |
octreotide |
Inferred relationship |
Some |
344775437 |
Octreotide (DBL) 500 microgram/mL injection, vial |
has Australian BoSS |
True |
octreotide |
Inferred relationship |
Some |
1677983892 |
Octreotide (DBL) 500 microgram/mL injection, vial |
has intended active ingredient |
True |
octreotide |
Inferred relationship |
Some |
1677983892 |
Octreotide (Sun) 50 microgram/mL injection, ampoule |
has Australian BoSS |
True |
octreotide |
Inferred relationship |
Some |
991180980 |
Sandostatin LAR (octreotide 10 mg) modified release injection, 10 mg vial |
has intended active ingredient |
True |
octreotide |
Inferred relationship |
Some |
2050882484 |
Octreotide (Hospira) 500 microgram/mL injection, vial |
has intended active ingredient |
True |
octreotide |
Inferred relationship |
Some |
394337314 |
Sandostatin 100 microgram/mL injection, ampoule |
has Australian BoSS |
True |
octreotide |
Inferred relationship |
Some |
2101123316 |
Sandostatin LAR (octreotide 30 mg) modified release injection, 30 mg vial |
has intended active ingredient |
True |
octreotide |
Inferred relationship |
Some |
572034164 |
Octreotide (Sun) 500 microgram/mL injection, ampoule |
has intended active ingredient |
True |
octreotide |
Inferred relationship |
Some |
525440716 |
octreotide |
has intended active ingredient |
True |
octreotide |
Inferred relationship |
Some |
1 |
octreotide 500 microgram/mL injection, vial |
has intended active ingredient |
True |
octreotide |
Inferred relationship |
Some |
240281904 |
octreotide 500 microgram/mL injection, vial |
has Australian BoSS |
True |
octreotide |
Inferred relationship |
Some |
240281904 |
octreotide 50 microgram/mL injection, ampoule |
has intended active ingredient |
True |
octreotide |
Inferred relationship |
Some |
996224734 |
octreotide 50 microgram/mL injection, ampoule |
has Australian BoSS |
True |
octreotide |
Inferred relationship |
Some |
996224734 |
octreotide 50 microgram/mL injection, vial |
has intended active ingredient |
True |
octreotide |
Inferred relationship |
Some |
956540964 |
octreotide 50 microgram/mL injection, vial |
has Australian BoSS |
True |
octreotide |
Inferred relationship |
Some |
956540964 |
octreotide 100 microgram/mL injection, ampoule |
has intended active ingredient |
True |
octreotide |
Inferred relationship |
Some |
362922000 |
octreotide 100 microgram/mL injection, ampoule |
has Australian BoSS |
True |
octreotide |
Inferred relationship |
Some |
362922000 |
octreotide 500 microgram/mL injection, ampoule |
has intended active ingredient |
True |
octreotide |
Inferred relationship |
Some |
1021448422 |
octreotide 500 microgram/mL injection, ampoule |
has Australian BoSS |
True |
octreotide |
Inferred relationship |
Some |
1021448422 |
octreotide 100 microgram/mL injection, vial |
has intended active ingredient |
True |
octreotide |
Inferred relationship |
Some |
2115667296 |
octreotide 100 microgram/mL injection, vial |
has Australian BoSS |
True |
octreotide |
Inferred relationship |
Some |
2115667296 |
Octreotide (Sun) 500 microgram/mL injection, ampoule |
has Australian BoSS |
True |
octreotide |
Inferred relationship |
Some |
525440716 |
Sandostatin (octreotide 500 microgram / 1 mL) injection, 1 mL ampoule (trade product unit of use) |
has intended active ingredient |
True |
octreotide |
Inferred relationship |
Some |
2091172180 |
octreotide 30 mg modified release injection, vial |
has intended active ingredient |
True |
octreotide |
Inferred relationship |
Some |
1089293202 |
octreotide 30 mg modified release injection, vial |
has Australian BoSS |
True |
octreotide |
Inferred relationship |
Some |
1089293202 |
octreotide 20 mg modified release injection, 20 mg vial (medicinal product unit of use) |
has intended active ingredient |
True |
octreotide |
Inferred relationship |
Some |
973095014 |
octreotide 20 mg modified release injection, 20 mg vial (medicinal product unit of use) |
has Australian BoSS |
True |
octreotide |
Inferred relationship |
Some |
973095014 |
octreotide 10 mg modified release injection, vial |
has intended active ingredient |
True |
octreotide |
Inferred relationship |
Some |
1858384150 |
octreotide 10 mg modified release injection, vial |
has Australian BoSS |
True |
octreotide |
Inferred relationship |
Some |
1858384150 |
Octreotide (DBL) 50 microgram/mL injection, vial |
has intended active ingredient |
True |
octreotide |
Inferred relationship |
Some |
1093072980 |
Octreotide (Sun) 100 microgram/mL injection, ampoule |
has intended active ingredient |
True |
octreotide |
Inferred relationship |
Some |
1912302356 |
Octreotide (MaxRx) 500 microgram/mL injection, ampoule |
has intended active ingredient |
True |
octreotide |
Inferred relationship |
Some |
1188972434 |
Octreotide (Hospira) 50 microgram/mL injection, vial |
has intended active ingredient |
True |
octreotide |
Inferred relationship |
Some |
1376367254 |
Octreotide (Hospira) 100 microgram/mL injection, vial |
has intended active ingredient |
True |
octreotide |
Inferred relationship |
Some |
1179602348 |
Sandostatin 50 microgram/mL injection, ampoule |
has intended active ingredient |
True |
octreotide |
Inferred relationship |
Some |
1641047188 |
Octreotide (DBL) 50 microgram/mL injection, vial |
has Australian BoSS |
True |
octreotide |
Inferred relationship |
Some |
1093072980 |
Octreotide (MaxRx) 100 microgram/mL injection, ampoule |
has Australian BoSS |
True |
octreotide |
Inferred relationship |
Some |
169461820 |
Sandostatin LAR (octreotide 20 mg) modified release injection, 20 mg vial |
has Australian BoSS |
True |
octreotide |
Inferred relationship |
Some |
708528428 |
Octreotide (MaxRx) 500 microgram/mL injection, ampoule |
has Australian BoSS |
True |
octreotide |
Inferred relationship |
Some |
1188972434 |
Octreotide (Hospira) 50 microgram/mL injection, vial |
has Australian BoSS |
True |
octreotide |
Inferred relationship |
Some |
1376367254 |
Sandostatin LAR (octreotide 30 mg) modified release injection, 30 mg vial |
has Australian BoSS |
True |
octreotide |
Inferred relationship |
Some |
572034164 |
Octreotide (Sun) 100 microgram/mL injection, ampoule |
has Australian BoSS |
True |
octreotide |
Inferred relationship |
Some |
1912302356 |
Sandostatin LAR (octreotide 10 mg) modified release injection, 10 mg vial |
has Australian BoSS |
True |
octreotide |
Inferred relationship |
Some |
2050882484 |
Octreotide (Hospira) 100 microgram/mL injection, vial |
has Australian BoSS |
True |
octreotide |
Inferred relationship |
Some |
1179602348 |
Sandostatin 50 microgram/mL injection, ampoule |
has Australian BoSS |
True |
octreotide |
Inferred relationship |
Some |
1641047188 |
Octreotide (Sun) 50 microgram/mL injection, ampoule |
has intended active ingredient |
True |
octreotide |
Inferred relationship |
Some |
991180980 |
Octreotide (DBL) 100 microgram/mL injection, vial |
has intended active ingredient |
True |
octreotide |
Inferred relationship |
Some |
1476625300 |
Octreotide (Hospira) 500 microgram/mL injection, vial |
has Australian BoSS |
True |
octreotide |
Inferred relationship |
Some |
394337314 |
Octreotide (MaxRx) 100 microgram/mL injection, ampoule |
has intended active ingredient |
True |
octreotide |
Inferred relationship |
Some |
169461820 |
Sandostatin LAR (octreotide 20 mg) modified release injection, 20 mg vial |
has intended active ingredient |
True |
octreotide |
Inferred relationship |
Some |
708528428 |
Octreotide (MaxRx) 50 microgram/mL injection, ampoule |
has intended active ingredient |
True |
octreotide |
Inferred relationship |
Some |
1718890274 |
Octreotide (MaxRx) 50 microgram/mL injection, ampoule |
has Australian BoSS |
True |
octreotide |
Inferred relationship |
Some |
1718890274 |
Sandostatin (octreotide 500 microgram / 1 mL) injection, 1 mL ampoule (trade product unit of use) |
has Australian BoSS |
True |
octreotide |
Inferred relationship |
Some |
2091172180 |
Sandostatin 100 microgram/mL injection, ampoule |
has intended active ingredient |
True |
octreotide |
Inferred relationship |
Some |
2101123316 |
Octreotide (DBL) 100 microgram/mL injection, vial |
has Australian BoSS |
True |
octreotide |
Inferred relationship |
Some |
1476625300 |